Lonza buys five US CDMO sites from Merck KGaA, adding ADC conjugation, viral vector, and LNP manufacturing as CDMO ...

Investment will scale nPhase’s enterprise clinical data business and accelerate expansion of its Statistical Computing Environment (SCE), Unified Data Management System (UDMS), and agentic AI ...

Andrea Corona is the senior editor at Drug Discovery News, where she leads daily editorial planning and produces original reporting on breakthroughs in drug discovery and development. With a ...

Quantum computing could help tackle some of drug discovery’s most difficult calculations. But better hardware, hybrid workflows, and closer collaboration with pharma will be needed to turn that ...

No VAV1 drug has reached approval, and four are now in development. Insilico’s AI-designed degrader makes its case on where ...

GLP-1 manufacturing challenges have become the binding constraint on one of the most successful drug classes in history. Demand for semaglutide and tirzepatide outran the industry’s ability to make ...

GLP-1 receptor agonists have become the defining drug class of the decade. Initially developed to treat diabetes, they have exploded into the mainstream as powerful weight-loss agents, reshaping not ...

Across SLAS Europe 2026, the focus was on AI and automation, but the tone was notably pragmatic. While AI featured heavily across keynote sessions and vendor demonstrations, the emphasis was less on ...

Drug responses in 3D models develop gradually over time, affecting their morphology, viability, and functional behavior. Live ...